Topic Chemotherapy
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Finds Link Between Lorazepam & Worse Outcomes in Pancreatic Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1023Published: October 2023Expires: 9/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Dabrafenib Plus Trametinib Shows Promise in BRAFV600E-Mutated Rare Cancers
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0723Published: July 2023Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, OncologyTopics: Cancer , Chemotherapy -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Explores Microbes in Breast Tumors from Women of Different Races
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0623Published: June 2023Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Combination Treatment for Endometrial Cancer Significantly Improves PFS
Price: $12.95Credits:
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0523Published: May 2023Expires: 3/6/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Topics: Cancer , Chemotherapy -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Febrile Neutropenia in the Chemotherapy Patient
Price: $21.95Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: AJN0523Published: May 2023Expires: 3/6/2026Sources: AJN, American Journal of NursingDetailsRequired Passing Score: 8/10 (80%)Collections: CESaverSpecialties: Acute Care, Ambulatory Care, Critical Care, Emergency, Medical-Surgical, Oncology, Primary Care -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} CAR T-Cell Therapy Shows Superior PFS in R/R Multiple Myeloma
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0423Published: April 2023Expires: 3/6/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Off-the-Shelf Multivirus-Specific T-Cell Therapy Shows Promise in Post-HCT Setting
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0323Published: March 2023Expires: 3/6/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, OncologyTopics: Cancer , Chemotherapy -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Research Highlights Role of Adjuvant Chemotherapy in Pancreatic Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0223Published: February 2023Expires: 12/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Relatlimab + Nivolumab Combination Effective in Stage III Melanoma
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1222Published: December 2022Expires: 12/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pembrolizumab With Etoposide/Platinum for First-line Small Cell lung Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1122Published: November 2022Expires: 9/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)